Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ · Manufacturing · Pharmaceutical preparations
$26.92+$0.6500 (+2.47%) on the dayAs of the close; data may be delayed.
ARQT price, last 12 months
Key stats
- Previous close
- $26.27
- Open
- $26.55
- Day range
- $25.80 – $27.09
- 52-week range
- $16.57 – $31.77
- Volume
- 2M
- Avg volume (20 days)
- 3.3M
- Market cap
- $3.4B
Performance
1W+6.1%
1M+7.1%
3M−0.3%
6M+20.3%
YTD−7.3%
1Y+55.6%
vs S&P 500, 1Y+38.8 pts
Technicals and fundamentals
About Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $3.4B